Senior insider sale
ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$1.01M
52.08K shares
What this filing means
GRIFFIN MICHELLE RENEE plans to sell 52.08K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $1.01M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2026ACC: 0001950047-26-006507
Director
Since Jun 2019
52.08K
Shares to sell
$1.01M
Approx. market value
52.08K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
6/25/2026
52.08KTotal acquired52.08K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/25/2026 | Exercise of Stock Options Cash | 52.08K | — |
| Total | 52.08K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
52.08K
Market value
$1.01M
6/25/2026
Total
Units
52.08K
Value
$1.01M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/25/2026 | 52.08K | $1.01M | NASDAQ | Planned |
| Total | 52.08K | $1.01M | ||